CABA: Cabaletta Bio, Inc.
Performance
CABA -41.18%
Watchlist
Select an item
Summary
CABA at a glance
CABA returned -41.18% over the past year and -34.95% a year over five years. Its worst drop in that year was -69.16%, smaller than 6% of stocks on Redstone, and its Sharpe ratio of -0.29 beats 16% of stocks on Redstone. It pays no dividends.
Current Drawdown
-63.86%
Rolling Volatility
101.97%
Actions
Metrics
Risk Indicators
Alpha-40.23%
Beta1.67x
Sharpe-0.29
Sortino-0.46
Omega0.95
Calmar-0.60
Martin-0.82
Profile
About CABA
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $254M
- Listed
- Oct 2019
- Employees
- 158
- Headquarters
- Philadelphia, PA
- Website
- cabalettabio.com
Comparisons